Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/52426
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Le Bin, Gloryn Chia | en_US |
dc.contributor.author | Muñoz-Descalzo, Silvia | en_US |
dc.contributor.author | Kurowski, Agata | en_US |
dc.contributor.author | Leitch, Harry | en_US |
dc.contributor.author | Lou, Xinghua | en_US |
dc.contributor.author | Mansfield, William | en_US |
dc.contributor.author | Etienne-Dumeau, Charles | en_US |
dc.contributor.author | Grabole, Nils | en_US |
dc.contributor.author | Mulas, Carla | en_US |
dc.contributor.author | Niwa, Hitoshi | en_US |
dc.contributor.author | Hadjantonakis, Anna Katerina | en_US |
dc.contributor.author | Nichols, Jennifer | en_US |
dc.date.accessioned | 2018-11-25T20:14:07Z | - |
dc.date.available | 2018-11-25T20:14:07Z | - |
dc.date.issued | 2014 | en_US |
dc.identifier.issn | 0950-1991 | en_US |
dc.identifier.uri | http://hdl.handle.net/10553/52426 | - |
dc.description.abstract | The transcription factor Oct4 is required in vitro for establishment and maintenance of embryonic stem cells and for reprogramming somatic cells to pluripotency. In vivo, it prevents the ectopic differentiation of early embryos into trophoblast. Here, we further explore the role of Oct4 in blastocyst formation and specification of epiblast versus primitive endoderm lineages using conditional genetic deletion. Experiments involving mouse embryos deficient for both maternal and zygotic Oct4 suggest that it is dispensable for zygote formation, early cleavage and activation of Nanog expression. Nanog protein is significantly elevated in the presumptive inner cell mass of Oct4 null embryos, suggesting an unexpected role for Oct4 in attenuating the level of Nanog, which might be significant for priming differentiation during epiblast maturation. Induced deletion of Oct4 during the morula to blastocyst transition disrupts the ability of inner cell mass cells to adopt lineage-specific identity and acquire the molecular profile characteristic of either epiblast or primitive endoderm. Sox17, a marker of primitive endoderm, is not detected following prolonged culture of such embryos, but can be rescued by provision of exogenous FGF4. Interestingly, functional primitive endoderm can be rescued in Oct4-deficient embryos in embryonic stem cell complementation assays, but only if the host embryos are at the pre-blastocyst stage. We conclude that cell fate decisions within the inner cell mass are dependent upon Oct4 and that Oct4 is not cell-autonomously required for the differentiation of primitive endoderm derivatives, as long as an appropriate developmental environment is established. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Development (Cambridge) | en_US |
dc.source | Development (Cambridge)[ISSN 0950-1991],v. 141, p. 1001-1010 | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 320102 Genética clínica | en_US |
dc.subject.other | Blastocyst | en_US |
dc.subject.other | Chimaera | en_US |
dc.subject.other | Nanog | en_US |
dc.subject.other | Oct4 (Pou5f1) | en_US |
dc.subject.other | Primitive endoderm | en_US |
dc.subject.other | Sox17 | en_US |
dc.title | Oct4 is required for lineage priming in the developing inner cell mass of the mouse blastocyst | en_US |
dc.type | info:eu-repo/semantics/article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1242/dev.096875 | en_US |
dc.identifier.scopus | 84894067021 | - |
dc.contributor.authorscopusid | 55872680700 | - |
dc.contributor.authorscopusid | 9235908900 | - |
dc.contributor.authorscopusid | 27368155400 | - |
dc.contributor.authorscopusid | 18042063600 | - |
dc.contributor.authorscopusid | 36154372500 | - |
dc.contributor.authorscopusid | 26635485100 | - |
dc.contributor.authorscopusid | 56037315600 | - |
dc.contributor.authorscopusid | 55179392700 | - |
dc.contributor.authorscopusid | 55819788000 | - |
dc.contributor.authorscopusid | 56429875100 | - |
dc.contributor.authorscopusid | 6701560632 | - |
dc.contributor.authorscopusid | 7201486017 | - |
dc.description.lastpage | 1010 | en_US |
dc.description.firstpage | 1001 | en_US |
dc.relation.volume | 141 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.description.numberofpages | 10 | en_US |
dc.utils.revision | Sí | en_US |
dc.date.coverdate | Marzo 2014 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.sjr | 5,204 | - |
dc.description.jcr | 6,462 | - |
dc.description.sjrq | Q1 | - |
dc.description.jcrq | Q1 | - |
dc.description.scie | SCIE | - |
item.fulltext | Sin texto completo | - |
item.grantfulltext | none | - |
crisitem.author.dept | GIR IUIBS: Diabetes y endocrinología aplicada | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Morfología | - |
crisitem.author.orcid | 0000-0003-0939-7721 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Muñoz Descalzo, Silvia | - |
Appears in Collections: | Artículos |
SCOPUSTM
Citations
136
checked on Sep 29, 2024
WEB OF SCIENCETM
Citations
128
checked on Sep 29, 2024
Page view(s)
52
checked on Feb 18, 2024
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.